Protagonist Therapeutics Inc (PTGX)
Stock-Based Compensation
$14.04M
Quarterly · Period ending: · USD
PTGX Stock-Based Compensation
Latest reported$14.04Mperiod ending
Latest reported$14.04Mperiod ending
PTGX Quarterly Stock-Based Comp ($19.00K → $14.04M)
Quarterly stock-based compensation
High-resolution chart · PNG
PTGX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 14,037,000 | |
| 14,519,000 | |
| 10,701,000 | |
| 10,559,000 | |
| 10,912,000 | |
| 13,802,000 | |
| 9,093,000 | |
| 10,165,000 | |
| 8,944,000 | |
| 9,352,000 | |
| 6,601,000 | |
| 6,765,000 | |
| 8,343,000 | |
| 7,584,000 | |
| 5,512,000 | |
| 5,950,000 | |
| 6,805,000 | |
| 5,935,000 | |
| 5,024,000 | |
| 4,775,000 | |
| 3,936,000 | |
| 2,660,000 | |
| 1,967,000 | |
| 1,888,000 | |
| 1,996,000 | |
| 2,048,000 | |
| 0 | |
| 2,201,000 | |
| 2,013,000 | |
| 1,979,000 | |
| 2,072,000 | |
| 2,017,000 | |
| 1,645,000 | |
| 1,185,000 | |
| 1,189,000 | |
| 1,207,000 | |
| 1,002,000 | |
| 843,000 | |
| 1,520,000 | |
| 448,000 | |
| 106,000 | |
| 56,000 | |
| 37,000 | |
| 22,000 | |
| 21,000 | |
| 19,000 |